Stem Cell Therapy Market Worth $558 Million, Future Prospects, Global Expansion, Business Planning and Forecast by 2027
In September 2020, Stemedica Cell Technologies received investigational new drug (IND) approval from the US FDA for intravenous allogeneic mesenchymal stem cells (MSCs) to treat moderate to severe COVID-19.
View full press release